Robert focuses on investing capital in venture and growth opportunities in the healthcare sector. He is a physician and former operating executive (Hansen Medical / robotics) with experience that spans investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities, and clinical services management. At Norwest he focuses on investing in category defining companies led by exceptional management teams. He currently serves on the boards of Qventus, Silk Road Medical, TigerConnect, and VisitPay, and is a board observer at Talkspace and Omada Health. He was a board member at iCardiac (acq. by eResearch), Telcare (acq. by BioTelemetry) and was a board observer at Crossover Health (acq. by Gurnet). Robert was a previous board observer at Intersect ENT (Nasdaq: XENT), and iRhythm Technologies (Nasdaq: IRTC). Robert was involved with the initial investments in Misfit Wearables (acq. by Fossil) and Health Catalyst. Robert is a Harvard / Stanford trained emergency physician who received his M.B.A from Harvard and has prior experience at Merck and the Boston Consulting Group. He received his B.S. in biomedical engineering from Johns Hopkins.